Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Question on valuing shares from time of spinoff

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Question on valuing shares from time of spinoff

bfw

Jul 18, 2018 01:19PM

Re: Question on valuing shares from time of spinoff

narmac

Jul 18, 2018 03:17PM

Re: Question on valuing shares from time of spinoff

KayakerBC

Jul 18, 2018 03:40PM

Re: Question on valuing shares from time of spinoff

chicagoest

Jul 18, 2018 04:13PM

tada

Rank: President [?]

Points: 7698 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Question on valuing shares from time of spinoff

in response to

Question on valuing shares from time of spinoff

bfw

posted on Jul 18, 2018 04:15PM

bfw - 5 years ago is a little stretch for my memory but .09 or .095 rings a bell. Personally I used zero and will us zero as a cost base when the shares get bought out, hopefully. Zenith is a reporting issuer as well as RVX so all of the information is available on SEDAR. It was May or June of 2013 when the split happened. The value the brokerage put on those shares means nothing at least in my case.

tada

3 Recommendations

Re: Question on valuing shares from time of spinoff

bfw

Jul 18, 2018 04:28PM

Re: Question on valuing shares from time of spinoff

tada

Sep 13, 2018 12:01AM

Re: Question on valuing shares from time of spinoff

tada

Sep 13, 2018 12:03AM

ACB of Zen shares